BMJ:covid-19大流行期间丹麦非covid疾病住院率下降、死亡率增高

2021-06-03 MedSci原创 MedSci原创

国家封锁期间所有主要非covid-19疾病组的住院人数均有所下降。总体死亡率和因呼吸系统疾病、癌症、肺炎和脓毒症入院的患者死亡率更高。有必要加强对非covid-19严重疾病的管理的关注

covid-19大流行造成了历史性的全球卫生危机,并迫使世界各国政府在国家内部和国家之间施加巨大限制。这些限制包括卫生预防措施和物理距离措施,如隔离、限制公共和私人聚会、关闭学校、公共工作场所、私营企业和国家边界。政府官员和医院管理人员也优先考虑医疗保健服务,以减少系统崩溃的风险。然而,这些自我隔离的优先事项和公共宣传活动可能会危及严重和急性非新冠肺炎患者。以往对大流行期间住院率进行的研究主要集中在单一的非covid-19急性疾病上,而且大多数研究在相对较短的时间内仅限于某一医疗保健计划或地理区域内的一家或几家医院。在危机时刻对基本卫生保健服务进行分析,对于管理医院应对措施和确保在covid-19持续威胁和未来流行病期间做好准备至关重要。 Jacob Bodilsen等的研究利用丹麦人口保健登记处的数据,调查了covid-19大流行前11个月丹麦住院和死亡率的变化。了解2019年3月13日至2021年1月27日丹麦非covid-19疾病住院率及相关死亡率。 该研究纳入所有丹麦1岁以上居民。利用包括整个丹麦人口的基于人口的医疗保健登记,将covid-19大流行期间(2020年3月11日至

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849265, encodeId=11f018492650e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 16 19:04:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561644, encodeId=7dd31561644b2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567653, encodeId=bf96156e6535f, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970472, encodeId=81e29e047215, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0e28c3efb48e4e09b819b11aafb285fa/714d8655280f42b0b5020b872148186c.jpg, createdBy=e1212204530, createdName=ANNIETIGER, createdTime=Thu Jun 03 00:36:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970467, encodeId=07f99e0467c4, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e495512180, createdName=杨朝华, createdTime=Thu Jun 03 00:18:40 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2022-02-16 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849265, encodeId=11f018492650e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 16 19:04:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561644, encodeId=7dd31561644b2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567653, encodeId=bf96156e6535f, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970472, encodeId=81e29e047215, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0e28c3efb48e4e09b819b11aafb285fa/714d8655280f42b0b5020b872148186c.jpg, createdBy=e1212204530, createdName=ANNIETIGER, createdTime=Thu Jun 03 00:36:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970467, encodeId=07f99e0467c4, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e495512180, createdName=杨朝华, createdTime=Thu Jun 03 00:18:40 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-06-04 liuxiaona
  3. [GetPortalCommentsPageByObjectIdResponse(id=1849265, encodeId=11f018492650e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 16 19:04:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561644, encodeId=7dd31561644b2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567653, encodeId=bf96156e6535f, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970472, encodeId=81e29e047215, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0e28c3efb48e4e09b819b11aafb285fa/714d8655280f42b0b5020b872148186c.jpg, createdBy=e1212204530, createdName=ANNIETIGER, createdTime=Thu Jun 03 00:36:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970467, encodeId=07f99e0467c4, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e495512180, createdName=杨朝华, createdTime=Thu Jun 03 00:18:40 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1849265, encodeId=11f018492650e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 16 19:04:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561644, encodeId=7dd31561644b2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567653, encodeId=bf96156e6535f, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970472, encodeId=81e29e047215, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0e28c3efb48e4e09b819b11aafb285fa/714d8655280f42b0b5020b872148186c.jpg, createdBy=e1212204530, createdName=ANNIETIGER, createdTime=Thu Jun 03 00:36:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970467, encodeId=07f99e0467c4, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e495512180, createdName=杨朝华, createdTime=Thu Jun 03 00:18:40 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-06-03 ANNIETIGER

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1849265, encodeId=11f018492650e, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Feb 16 19:04:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561644, encodeId=7dd31561644b2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567653, encodeId=bf96156e6535f, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Fri Jun 04 15:04:28 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970472, encodeId=81e29e047215, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200904/0e28c3efb48e4e09b819b11aafb285fa/714d8655280f42b0b5020b872148186c.jpg, createdBy=e1212204530, createdName=ANNIETIGER, createdTime=Thu Jun 03 00:36:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970467, encodeId=07f99e0467c4, content=很棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e495512180, createdName=杨朝华, createdTime=Thu Jun 03 00:18:40 CST 2021, time=2021-06-03, status=1, ipAttribution=)]
    2021-06-03 杨朝华

    很棒

    0

相关资讯

BMC Gastroenterology:医疗单位年度肝移植手术量与患者术后死亡率的关系

肝移植 (LT) 是一项重大而、困难的手术,需要涉及多个医疗团队进行相互配合。活体肝移植与移植后手术并发症较高,住院死亡率介于3.6至18.9%之间。

JNCI:近20年来肝癌的死亡率变化趋势

原发性肝癌的死亡率已开始降低~

Crit Care:呼吸机相关性肺炎与COVID-19患者死亡率之间的关系

VAP与SARS-CoV-2患者的28天死亡率增加显著相关。但是,与流感性肺炎患者或无病毒感染患者相比,SARS-CoV-2肺炎并未显著改变VAP与28天死亡率之间的关系。

Stroke:缺血性卒中或TIA患者去强化或不接受他汀类药物治疗会导致更高的死亡率

约有三分之一的缺血性卒中或TIA退伍军人采用他汀类药物治疗不充分,包括中风后未接受他汀类药物治疗或剂量不足(去强化),且与患者较高的死亡率相关。

Clin Nutr:早期肠内营养对重大急诊腹部手术后死亡率的影响

重大急诊腹部手术的特点是术后发生的并发症和死亡率较高,一般来说为了避免术后出现腹胀,恶心,呕吐等并发症,术前是不允许进行进食的。

Br J Cancer:低脂饮食可降低乳腺癌死亡率

代谢综合征(MS)通常表现为腹部肥胖、高血压、高密度胆固醇(HDL)降低、甘油三酯的升高和葡萄糖水平的升高,其与心血管疾病、糖尿病和其他包括乳腺癌在内的其他慢性疾病的患病风险升高相关。